Stock Track | Option Care Health Plunges 5.82% Pre-Market Despite Q3 Earnings Beat as 2025 Guidance Disappoints

Stock Track10-30

Option Care Health Inc (OPCH) shares tumbled 5.82% in pre-market trading on Thursday, despite reporting better-than-expected third-quarter results. The sharp decline appears to be driven by the company's full-year 2025 guidance, which fell short of some investor expectations.

For the third quarter ended September 30, 2025, Option Care Health reported revenue of $1.435 billion, up 12.2% year-over-year and surpassing the analyst consensus of $1.412 billion. The company's adjusted earnings per share (EPS) came in at $0.45, beating the estimated $0.42. Adjusted EBITDA for the quarter was $119.5 million, also exceeding the expected $118.4 million.

However, the company's outlook for the full year 2025 seems to have disappointed investors. Option Care Health expects net revenue between $5.60 billion and $5.65 billion, which is in line with the current FactSet estimate of $5.63 billion. The adjusted EPS guidance of $1.68 to $1.72 also aligns with the consensus estimate of $1.71. Despite meeting expectations, the guidance may not have been strong enough to justify the stock's recent valuation, leading to the sell-off. Additionally, the company's projected adjusted EBITDA of $468 million to $473 million for 2025 might have fallen short of some investors' more optimistic projections, contributing to the negative sentiment in pre-market trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment